Cleared Traditional

K201948 - AcroDTI Visualizer

K201948 is the FDA 510(k) clearance for AcroDTI Visualizer by Acroviz, Inc.. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 58-day FDA review.

K201948 · Acroviz, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2020
Decision
58d
Days
Class 2
Risk

K201948 is an FDA 510(k) clearance for the AcroDTI Visualizer. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Acroviz, Inc. (Taipei, TW). The FDA issued a Cleared decision on September 9, 2020 after a review of 58 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Acroviz, Inc. devices

Submission Details

510(k) Number K201948 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 13, 2020
Decision Date September 09, 2020
Days to Decision 58 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
49d faster than avg
Panel avg: 107d · This submission: 58d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1056
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K201948.
AVA (Augmented Vascular Analysis)
K201369 · See-Mode Technologies Pte, Ltd. · Sep 2020
Collaboration Live
K201665 · Philips Ultrasound, Inc. · Sep 2020
Aline Ablation Intelligence
K202297 · Mirada Medical, Ltd. · Sep 2020
3Shape Implant Studio
K202256 · 3Shape Medical A/S · Sep 2020
Ambra ProViewer
K202335 · Dicom Grid Inc Dba Ambra Health · Sep 2020
Synapse 3D Cardiac Tools
K200973 · Fujifilm Corporaton · Aug 2020